Analysis Of Clinical Feature Of Onset Hyperthyroid With Leucopenia

Objective Preliminary studies on the thyroid function in patients with hyperthyroidism interleukin the basis of the value as well as the beginning of the hyperthyroid patients with the impact of interleukin. Method I collect hospital from December 2006 to December 2007 by the administration of the 208 patients with first clinical data of patients with hyperthyroidism, observation of their age, disease, peripheral blood leukocytes, neutrophils, and other aspects of the relationship between the primary hyperthyroidism Interleukin with the basis of value and the beginning of the patients with hyperthyroidism on the impact of interleukin.Results The group of 208 cases of hyperthyroidism in patients with early merger leukopenia, 34 cases, the merger leukopenia Group 174 cases, statistics show that compared the two groups, age, and neutrophil leukocytes There was a statistical difference between the two groups course Contrast no significant difference by the statistics, primary basis of the white blood cells in patients with hyperthyroidism value (5.5±1.75)×109 / L.Conclusions Old age is the beginning of the hyperthyroidism leukopenia a major influencing factors, the length of the course and there is no significant relationship between the two groups compared neutrophil leukocytes and a statistically significant difference in the early hyperthyroid patients can have the WBC and tablets cells reduced early this group of 208 patients with hyperthyroidism basic value of interleukin (5.5±1.75)×109 / L, in the normal assembly line. The initial group of 208 cases of hyperthyroidism, which merged peripheral blood leukocyte reduction of the 34 cases, patients with hyperthyroidism, early leukocyte reduction in the prevalence rate of 16.35%, the treatment for newly diagnosed patients with hyperthyroidism before blood must be observed, Treatment of patients with Graves disease patients should get regular reexamination of missionary work, periodic review of blood and thyroid function and anti-thyroid drug dose adjustments, and should be in the early stages of governance do weekly blood leukocyte classification and the total number of 1 - 2 times, close observation of blood changes in order not to increase the level of leukocyte reduction.